Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | ADH1B | P00325 | 2/20 | 0.46 |
| ▸ | ADH1C | P00326 | 2/20 | 0.46 |
| ▸ | ADH1A | P07327 | 2/20 | 0.46 |
| ▸ | ADH4 | P08319 | 2/20 | 0.46 |
| ▸ | ADH7 | P40394 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.45 |
| ▸ | GAPDH | P04406 | 1/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | FDPS | P14324 | 4/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | LAP3 | P28838 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17062948 | 0.97 | TSHR (0.65) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL9396374 | 0.97 | TSHR (0.65) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL9395677 | 0.97 | TSHR (0.65) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL6196083 | 0.97 | TSHR (0.65) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL9397942 | 0.97 | TSHR (0.65) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL23851480 | 0.97 | TSHR (0.65) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL9714695 | 0.97 | TSHR (0.65) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL9395399 | 0.97 | TSHR (0.65) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL21694562 | 0.97 | TSHR (0.65) | TSHRSMN1; SMN2ADH1BADH1CADH1A | |
| SCHEMBL9395696 | 0.97 | TSHR (0.65) | TSHRSMN1; SMN2ADH1BADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260060926-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SAIL BIOMEDICINES INC (US) | 2026-03-05 | — | — | US | disclosed |
| EP-4581012-A2 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | Sail Biomedicines, Inc. (US) | 2025-07-09 | — | — | EP | disclosed |
| US-20250049948-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SAIL BIOMEDICINES, INC. | 2025-02-13 | — | — | US | disclosed |
| US-20250051263-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SAIL BIOMEDICINES, INC. | 2025-02-13 | — | — | US | disclosed |
| EP-4436549-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | Sail Biomedicines, Inc. (US) | 2024-10-02 | — | — | EP | disclosed |
| EP-4433450-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | Sail Biomedicines, Inc. (US) | 2024-09-25 | — | — | EP | disclosed |
| WO-2024049979-A2 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SENDA BIOSCIENCES, INC. (US) | 2024-03-07 | — | — | WO | disclosed |
| WO-2023091490-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SENDA BIOSCIENCES, INC. (US) | 2023-05-25 | — | — | WO | disclosed |
| WO-2023091787-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SENDA BIOSCIENCES, INC. (US) | 2023-05-25 | — | — | WO | disclosed |
| EP-3733647-B1 | CATIONIC LIPID | EISAI R&D MAN CO LTD (JP) | 2022-06-15 | — | — | EP | disclosed |
| EP-0329670-A1 | A PROCESS FOR THE HYDROFORMYLATION OF SULFUR-CONTAINING THERMALLY CRACKED PETROLEUM RESIDUA AND NOVEL PRODUCTS THEREOF. | EXXON RESEARCH ENGINEERING CO (US) | 1989-08-30 | — | — | EP | disclosed |
| EP-0329670-A4 | A PROCESS FOR THE HYDROFORMYLATION OF SULFUR-CONTAINING THERMALLY CRACKED PETROLEUM RESIDUA AND NOVEL PRODUCTS THEREOF. | EXXON RESEARCH ENGINEERING CO (US) | 1989-08-16 | — | — | EP | disclosed |
| WO-1988002360-A1 | A PROCESS FOR THE HYDROFORMYLATION OF SULFUR-CONTAINING THERMALLY CRACKED PETROLEUM RESIDUA AND NOVEL PRODUCTS THEREOF | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1988-04-07 | — | — | WO | disclosed |
| US-4711968-A | PRODUCTION OF ALDEHYDES AND ALCOHOLS USING TRANSITION METAL CARBONYL COMPLEX CATALYSTS | EXXON RESEARCH & ENGINEERING CO. (US) | 1987-12-08 | — | — | US | disclosed |
| US-4649204-A | ANTIDEPRESSANTS | MCNEILAB, INC. (US) | 1987-03-10 | — | — | US | disclosed |
| EP-0112821-B1 | PROCESS FOR PREPARING SATURATED DIMERIC KETONES | MOBIL OIL CORPORATION (US) | 1986-07-16 | — | — | EP | disclosed |
| EP-0112821-A4 | PROCESS FOR PREPARING SATURATED DIMERIC KETONES. | MOBIL OIL CORP (US) | 1984-10-29 | — | — | EP | disclosed |
| EP-0112821-A1 | PROCESS FOR PREPARING SATURATED DIMERIC KETONES. | MOBIL OIL CORP (US) | 1984-07-11 | — | — | EP | disclosed |
| WO-1984000160-A1 | PROCESS FOR PREPARING SATURATED DIMERIC KETONES | MOBIL OIL CORP (US) | 1984-01-19 | — | — | WO | disclosed |
| US-4339606-A | DIMERIZATION | MOBIL OIL CORPORATION (US) | 1982-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051263-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | NPC1L1, ABCB4, LIPA | TSHR 3809/4885SMN1; SMN2 2687/4885ADH1B 2606/4885 |
| US-20260060926-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SGMS1, NPC1L1, SGMS2 | TSHR 379/4885SMN1; SMN2 1074/4885ADH1B 2186/4885 |
| US-20250049948-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | NPC1L1, ABCB4, LIPA | TSHR 3809/4885SMN1; SMN2 2687/4885ADH1B 2606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.